Scores here are heuristic signals about sourcing and corroboration across outlets — not verdicts on whether a story is true, and not an endorsement or condemnation of any outlet. How this works
Michael Henderson and his C-suite from Apogee Therapeutics are reuniting to lead Paragon Labs. Paragon is the antibody discovery shop that planted the seed for Apogee’s pipeline four years ago.
1
independent outlets · 100% owner-diverse
Save this story
Connect "After $10.9B exit to AbbVie, Apogee execs join Paragon to scale its R&D, company creation engine - Endpoints News" to your own research notes and market positions — Next Level Intelligence links what you save to the assets and notes it actually affects.